Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borui Kang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
ACS Omega|April 19, 2021
From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same TargetMadhusoodanan Mottamal, Borui Kang, Xianyou Peng, et al.
Synthetic Communications|November 24, 2022
Design and synthesis of a novel ZB716-d6 as a stable isotopically labeled internal standardShilong Zheng, Jiawang Liu, Borui Kang, et al.
Neural Networks : the Official Journal of the International Neural Network Society|August 23, 2025
C<sup>3</sup>aptioner: Improving change captioning by leveraging momentum cross-view and cross-modality contrastive learningLin Deng, Borui Kang, Yuzhong Zhong, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME StudiesJiawang Liu, Nirmal Rajasekaran, Ahamed Hossain, et al.
IEEE Transactions on Medical Imaging|June 8, 2026
PathRWKV: Enhancing Whole Slide Image Inference with Asymmetric Recurrent ModelingTianyi Zhang, Sicheng Chen, Borui Kang, et al.
European Journal of Medicinal Chemistry|May 22, 2026
Developing orally active estrogen receptor degraders by conjugation of boronic tamoxifen and cereblon ligandsXianyou Peng, Ahamed Hossain, Peng Ma, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate CancerBorui Kang, Madhusoodanan Mottamal, Qiu Zhong, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
ACS Omega|April 19, 2021
From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same TargetMadhusoodanan Mottamal, Borui Kang, Xianyou Peng, et al.
Synthetic Communications|November 24, 2022
Design and synthesis of a novel ZB716-d6 as a stable isotopically labeled internal standardShilong Zheng, Jiawang Liu, Borui Kang, et al.
Neural Networks : the Official Journal of the International Neural Network Society|August 23, 2025
C<sup>3</sup>aptioner: Improving change captioning by leveraging momentum cross-view and cross-modality contrastive learningLin Deng, Borui Kang, Yuzhong Zhong, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME StudiesJiawang Liu, Nirmal Rajasekaran, Ahamed Hossain, et al.
IEEE Transactions on Medical Imaging|June 8, 2026
PathRWKV: Enhancing Whole Slide Image Inference with Asymmetric Recurrent ModelingTianyi Zhang, Sicheng Chen, Borui Kang, et al.
European Journal of Medicinal Chemistry|May 22, 2026
Developing orally active estrogen receptor degraders by conjugation of boronic tamoxifen and cereblon ligandsXianyou Peng, Ahamed Hossain, Peng Ma, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate CancerBorui Kang, Madhusoodanan Mottamal, Qiu Zhong, et al.
Pageof 1